SKNV's Fran Malkin Co-Authors "Flip the Script" with Best-Selling Author and Negotiation Icon Chris Voss

Launching today July 17, 2025 and available on Amazon

FORT LAUDERDALE, Fla., July 17, 2025 /PRNewswire/ -- SKNV, a leader in dermatologic innovation and custom prescription medications, proudly announces a landmark achievement by one of its senior leaders. Fran Malkin, SKNV Vice President of Education Development, has co-authored the newly released book Flip the Script, in collaboration with world-renowned negotiation expert and best-selling author Chris Voss, author of the acclaimed Never Split the Difference.

This prestigious collaboration showcases Fran's lifelong commitment to transformative education and her deep expertise in building empathy-driven learning cultures. Her contribution to Flip the Script reflects the innovation and human-centric leadership that define SKNV's approach to education and professional development.

"Throughout my career, I've learned that building the most impactful relationships—whether in a classroom or a dermatology office—start with empathy. Flip the Script gave me the opportunity to share how we can reframe conversations into moments of connection, clarity, and growth. I'm honored to be part of a book that challenges conventional thinking and inspires change through tactical empathy,"  said Fran Malkin, SKNV Vice President of Education Development.

This milestone is more than a personal success—it's a proud moment for the entire SKNV team. Fran's voice in Flip the Script exemplifies the organization's values: empathy, innovation, and the relentless pursuit of impactful education.

ABOUT THE BOOK

Flip the Script, released on July 17, 2025, explores how tactical empathy can reshape high-stakes conversations into breakthrough moments. Available on Amazon, the book features a collection of insights from thought leaders across sectors—each demonstrating how empathy can become a strategic advantage in communication, leadership, and connection.

Fran's chapter offers a compelling look at how empathy has guided her three-decade journey from the classroom to the corporate dermatology industry. Her writing distills practical lessons for educators, trainers, healthcare leaders, and anyone invested in human growth.

ABOUT FRAN MALKIN

Fran Malkin began her career as a high school and college educator, known for her dynamic teaching and mentorship. Over 20 years in traditional education, she shaped the learning experiences of students and future teachers alike. A decade ago, she transitioned into corporate training, bringing her academic insights to the healthcare and dermatology sectors.

Now serving as VP of Education Development at SKNV, a South Florida-based FDA-Registered 503B Outsourcing Facility, Fran leads national training programs designed to elevate provider communication, enhance learning outcomes, and promote patient-centered care. Her leadership style emphasizes active listening, mentorship, and collaborative learning, creating environments where teams thrive.

Outside of her professional work, Fran enjoys the beach, travel, and spending time with her husband Spencer and their two adult children, Reid and Ava.

ABOUT SKNV

Empowering Dermatology Practices. Enhancing Patient Access—SKNV is transforming dermatologic care with high-quality topical medications manufactured at its FDA-Registered 503B Outsourcing Facility. By eliminating common pharmacy barriers like prior authorizations, SKNV helps providers deliver more efficient, office-controlled care—whether through in-office dispensing or direct-to-patient prescriptions. Focused on treating conditions such as acne, melasma, rosacea, and alopecia, SKNV enables practices to streamline workflows while supporting patient satisfaction. Its formulations are made to the highest standards, often free from unnecessary excipients like allergens and irritants, where clinically appropriate. SKNV serves over 4,000 providers nationwide and continues to set new benchmarks in dermatology by making effective, practice-driven care more accessible.

Learn more at www.sknv.com and discover how FDA-Registered 503B Outsourcing Facilities enhance quality and supply at www.sknv.com/why-503b.

Media Contact: Morgan Miller
Email: [email protected]

SOURCE SKNV